Fig. 4From: Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathiesGlobal effects of brain aberrant metabolism on the composition of CSF. Univariate and multivariate analyses of metabolic patterns found in cerebrospinal fluid of 10-month-old SHR-24 Tg rats compared with age-matched controls. A Principal component analysis (PCA), and orthogonal partial least square discriminant analysis (OPLS-DA). B Metabolic map showing results from significance testing for lipids – student’s t-test (p-value and fold change). C Age-related changes of the most distinctive lipid classes (data are presented as median intensities with 95% confidence intervals). D Lipid ontology enrichment analysis. E Metabolic map showing results from significance testing for metabolites – student’s t-test and fold change. F Enrichment pathway analysis of metabolomics data. The biochemical pathways were evaluated using p-value and enrichment ratio. G Age-related changes of metabolites belong to the pathways: purine catabolism (xanthine, uric acid) and analytes of creatine/arginine metabolism (creatine, phosphocreatine, arginine), free carnitine, myoinositol and citrate + isocitrate (data are presented as median intensities with 95% confidence intervals). Abbreviations LPE – lysophosphatidylethanolamines, PE – phosphatidylethanolamines, PS – phosphatidylethanolserines, PC – phosphatidylcholines, LPC – lysophosphatidylcholines, SM – sphingomyelins, CER – ceramides, HCER – hexosyl-ceramides, H2CER – dihexosyl-ceramides, DAG – diacylglycerols, TAG – triacylglycerols, PI – phosphatidylinositols, PG – phosphatidylglycerols, CE – cholesteryl esters, FA – fatty acids, PCO – plasmenyl phosphatidylcholines, LPCO – plasmenyl lysophosphatidylcholines, PEO – plasmenyl phosphatidylethanolamines, LPEO – plasmenyl lysophosphatidylethanolaminesBack to article page